Group 1 - Company Sun Energy plans to repurchase shares worth between 100 million to 200 million yuan for cancellation, with a maximum repurchase price of 6.69 yuan per share [1] - Company Runyang Technology intends to invest up to 300 million yuan in Shanghai Fourier Intelligent Technology Co., with a pre-investment valuation of 8 billion yuan [1] - Company Heng Rui Medicine's subsidiary has received approval for clinical trials of SHR-4712 injection for treating advanced solid tumors [2] Group 2 - Company Lianhuan Pharmaceutical plans to increase capital by 60 million yuan for its wholly-owned subsidiary [2] - Company Hongchang Electronics' subsidiary plans to increase capital by 10 million USD for its other subsidiary [2] - Company Sichuan Meifeng intends to repurchase shares worth between 50 million to 70 million yuan for cancellation, with a maximum repurchase price of 10.07 yuan per share [2] Group 3 - Company Lian Micro plans to liquidate and deregister Jiaxing Kangjing Semiconductor Industry Investment Partnership [4] - Company Jiutian Pharmaceutical has received approval for clinical trials of PDX-04 drug for treating acute gout attacks [5] - Company Pingzhi Information has signed a framework agreement with China Telecom for a GPU computing power project worth approximately 246 million yuan [7] Group 4 - Company Jiu Zhi Tang's subsidiary has initiated Phase II clinical trials for new drug YB211 aimed at treating acute bacterial skin infections [8] - Company Fosun Pharma's subsidiary has received orphan drug designation for HLX22 for gastric cancer treatment in the EU [9] - Company Jianyou Co. plans to repurchase shares worth between 20 million to 40 million yuan for employee stock ownership plans [11] Group 5 - Company Zhi Zheng Co. announced the resignation of its vice president due to personal reasons [13] - Company He Mai Co. signed a cooperation agreement for household photovoltaic systems worth 1 billion yuan [14] - Company Jinan Intelligent's subsidiary won a project bid for electric vehicle charging stations, expected to positively impact performance [16] Group 6 - Company Gaotie Electric plans to distribute a cash dividend of 0.012 yuan per share [18] - Company Guyue Longshan plans to distribute a cash dividend of 0.08 yuan per share [18] - Company Yongmaotai's shareholders plan to reduce their holdings by up to 2.66% of the company's shares [19] Group 7 - Company Tian Cheng Technology's subsidiary received a land idle fee notice for 2.1658 million yuan due to project delays [20] - Company Guangri Co. appointed a new vice president and board secretary to enhance governance [21] - Company Design General Institute won multiple major projects totaling approximately 390 million yuan [22] Group 8 - Company Fuxie Environmental signed a significant contract worth 244 million yuan for a sewage treatment project [23] - Company Lujiazui announced the resignation of its vice chairman due to job transfer [24] - Company Three Squirrels' H-share issuance application has been accepted by the CSRC [24] Group 9 - Company Kanghong Pharmaceutical's subsidiary received approval for clinical trials of KH617 for glioblastoma treatment [25] - Company Xin Zhu Co. announced a suspension of trading to plan an asset acquisition from its controlling shareholder [26] - Company Jianxin Co. announced plans for share reductions by several directors and senior management [28]

截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任公司上海分公司（以下简 称"中国结算上海分公司"）登记在册的本公司全体股东。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次利润分配方案经公司2025年5月16日的2024年年度股东大会审议通过。 二、分配方案 1.发放年度：2024年年度 2.分派对象： 3.分配方案： 本次利润分配以方案实施前的公司总股本650,472,000股为基数，每股派发现金红利0.10元（含税），共 计派发现金红利65,047,200元。 三、相关日期 ■ 四、分配实施办法 1.实施办法 （1）无限售条件流通股的红利委托中国结算上海分公司通过其资金清算系统向股权登记日上海证券交 易所收市后登记在册并在上海证券交易所各会员办理了指定交易的股东派发。已办理指定交易的投资者 可于红利发放日在其指定的证券营业部领取现金红利，未办理指定交易的股东红利暂由中国结算上海分 公司保管，待办理指定交易后再进行派发。 （2）派送红股或转增股本的，由中国结算上海分公司根据股权登记日上 ...

Core Points - The company announced a cash dividend of 0.10 yuan per share for its A shares, totaling 65,047,200 yuan based on a total share capital of 650,472,000 shares [1][2] - The relevant dates for the dividend distribution include the record date on May 29, 2025, the last trading day on May 30, 2025, and the ex-dividend date also on May 30, 2025 [1][2] Dividend Distribution Details - The dividend distribution plan was approved at the annual general meeting held on May 16, 2025 [1] - The cash dividends will be distributed through China Securities Depository and Clearing Corporation Limited Shanghai Branch to shareholders registered by the record date [2] - Shareholders who have not completed designated transactions will have their dividends held by the clearing company until the transactions are completed [2] Taxation Information - Individual shareholders holding shares for over one year will not be subject to personal income tax on the dividend, while those holding for less than one month will be taxed at 20% [3][4] - Qualified Foreign Institutional Investors (QFII) will have a 10% withholding tax applied, resulting in a net dividend of 0.090 yuan per share [4][5] - For Hong Kong Stock Exchange investors, the same 10% withholding tax applies, leading to a net dividend of 0.090 yuan per share [5]

每股分配比例 A 股每股现金红利0.10元 证券代码：603012 证券简称：创力集团 公告编号：2025-024 相关日期 上海创力集团股份有限公司2024年年度权益分派实施公告 | 股份类别 | 股权登记日 | 最后交易日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | --- | --- | | Ａ股 | 2025/5/29 | － | 2025/5/30 | 2025/5/30 | 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 差异化分红送转： 否 3. 分配方案： 本次利润分配以方案实施前的公司总股本650,472,000股为基数，每股派发现金红利0.10 元（含税），共计派发现金红利65,047,200元。 1. 发放年度：2024年年度 2. 分派对象： 三、 相关日期 | 股份类别 | 股权登记日 | 最后交易日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | --- | --- | | Ａ股 | 2025/5/29 | － ...

证券代码：603012 证券简称：创力集团 公告编号：2025-023 上海创力集团股份有限公司 (一)股东大会召开的时间：2025 年 5 月 16 日 (二)股东大会召开的地点：上海市青浦区新康路 889 号 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： | 1、出席会议的股东和代理人人数 | 195 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 168,583,158 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | 份总数的比例（%） | 25.9170 | (四)表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 2024年年度股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 一、 会议召开和出席情况 本次会议由董事会召集，大会主持工作经董事会半数以上董事推举，由董事耿卫 东先生主持，投票方式采取现场投票和网络投票相结合的方式召开。本次会议的 召集、召开及 ...

法律意见书 上海市静安区山西北路 99 号苏河湾中心 MT25-28 楼 邮编：200085 25-28/F, Suhe Centre, 99 North Shanxi Road, Jing'an District, Shanghai, China 电话/Tel: (+86)(21) 5234 1668 传真/Fax: (+86)(21) 5234 1670 网址/Website: http://www.grandall.com.cn 国浩律师（上海）事务所 关于 上海创力集团股份有限公司 2024 年年度股东大会 之 二〇二五年五月 国浩律师（上海）事务所 法律意见书 国浩律师（上海）事务所 关于上海创力集团股份有限公司 2024 年年度股东大会 之 法律意见书 致：上海创力集团股份有限公司 作为具有从事中国法律业务资格的律师事务所，国浩律师（上海）事务所（以 下简称"本所"）接受上海创力集团股份有限公司（以下简称"公司"）的委托，根 据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人民共和国证 券法》（以下简称"《证券法》"）等法律法规及规范性文件的规定，指派本所律 师出席公司2024年年度股 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 上海创力集团股份有限公司（以下简称"本公司"或"公司"）于 2024 年 5 月 12 日 10:30-11:30 在上证路演中心（http://roadshow.sseinfo.com）采用网 络文字互动方式召开了"关于 2024 年度网上业绩暨分红说明会"。关于本次业绩 说明会的召开事项，公司已于 2025 年 4 月 26 日在《中国证券报》、《证券时报》 及上海证券交易所网站(http://www.sse.com.cn)披露了《创力集团关于 2024 年度网上业绩暨分红说明会预告公告》（公告编号：2025-021）。现将有关事项公 告如下： 证券代码：603012 证券简称：创力集团 公告编号： 2025-022 上海创力集团股份有限公司 关于 2024 年度网上业绩暨分红说明会 召开情况的公告 一、本次说明会召开情况 2025 年 5 月 12 日，公司董事、总经理张世洪先生、财务总监王天东先生、 董事会秘书常玉林先生、独立董事彭涛先生出席了本次业 ...

| | | | 2024 | 年度股东会参会须知 1 | | | --- | --- | --- | | 2024 | 年度股东会议程 | 2 | | 2024 | 年度股东会议案 | 4 | | | 议案 | 24 | 上海创力集团股份有限公司 2024 年度股东会 会议资料 证券代码：603012 二〇二五年五月十六日 2024 年度股东会参会须知 为维护投资者的合法权益，保障股东在公司 2024 年度股东会期间依法行使权力， 确保股东会的正常秩序和议事效率，依据中国证监会《上市公司股东会规则》及本公 司《股东会议事规则》的有关规定，特制定本须知。 一、请按照本次股东会会议通知（详见 2025 年 4 月 26 日刊登于上海证券交易所 网站 www.sse.com.cn 的《创力集团 2024 年度股东大会的通知》）中规定的时间和登记 方法办理参会会议手续，证明文件不齐或手续不全的，谢绝参会。 二、股东会设秘书处，具体负责大会有关各项事宜。 三、董事会以维护股东合法权益、确保股东会正常秩序和议事效率为原则，认真 履行法定职责。 四、股东参加股东会依法享有发言权、质询权、表决权等权利，同时也应履行法 定义务 ...

Core Points - The company has ensured the accuracy and completeness of the quarterly report, with all board members and management taking legal responsibility for its content [2][3][4] - The first quarter financial statements are unaudited, and the company has reported no significant changes in accounting data or financial indicators [3][5][6] - The company plans to distribute a cash dividend of RMB 1.00 per share, totaling RMB 65,047,200 based on a total share capital of 650,472,000 shares [13][14] - The board has approved a total of 13 research and development projects for 2025, including 9 new projects and 4 ongoing projects [35] - The company intends to provide a guarantee of up to RMB 286.4 million for its subsidiaries in 2025, which can be adjusted based on actual needs [37][38] - The company plans to apply for a comprehensive credit limit of up to RMB 3.2725 billion from banks for 2025 [41] - The company has approved the use of up to RMB 300 million of idle funds for purchasing financial products to improve fund utilization [46] - The company will provide financing lease guarantees totaling up to RMB 250 million for its clients [48] - The company has approved the continuation of its financial and internal control auditing services with Lixin Accounting Firm for 2025 [96][97] Financial Data - The company reported a total of RMB 1,043.33 million in salaries for senior management in 2024 [61] - The total remuneration for directors in 2024 was RMB 7.6707 million [54] - The company’s internal control evaluation report confirmed no significant deficiencies in financial reporting controls [84]

证券代码：603012 证券简称：创力集团 公告编号：2025-017 上海创力集团股份有限公司 关于使用自有资金购买理财产品的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 为提高公司资金利用率，合理利用闲置资金，在不影响公司正常经营生产 的前提下，公司拟使用最高额度不超过（含）人民币三亿元的闲置自有资金购 买理财产品。具体议案情况如下： 一、使用自有资金委托理财概况 （一）委托理财目的 为提高公司资金利用率，合理利用闲置资金，在不影响公司正常经营生产 的前提下，公司拟使用闲置自有资金购买风险较低的理财产品，为公司增加收 益。 （二）投资金额 公司拟使用最高额度不超过（含）人民币三亿元的闲置自有资金购买理财 产品。 （三）资金来源 公司闲置自有资金。 （四）投资方式 1 委托理财受托方：银行等金融机构 委托理财金额：不超过（含）人民币三亿元 委托理财投资类型：风险系数较低、安全性高、流动性较好的理财产品 委托理财期限：自董事会审议通过之日起 12 个月内有效。 公司将严格控制风险，将使用闲置自有资 ...